Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02080689 · ClinicalTrials.gov registry record · NA

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

A NA study of Prostate Cancer, sponsored by GenomeDx Biosciences.

Completed
Registry status
NA
Development phase
286
Enrollment target
19
Study locations

NCT02080689: Completed NA study of Prostate Cancer, sponsored by GenomeDx Biosciences.

NCT02080689 is a NA study of Prostate Cancer that has completed, run by GenomeDx Biosciences. The registered enrollment target is 286 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (53% lower). The trial reports 19 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02080689, a NA study of Prostate Cancer, has completed, sponsored by GenomeDx Biosciences.

COMPLETED
Registry status
NA
Development phase
286 participants
Enrollment target
19
Study locations

Study Summary

The influence of Decipher test on urologist and patient treatment plan choices immediately post RP and at the time of PSA rise or BCR

Conditions Studied

Prostate Cancer

Interventions

  • OTHER Decipher

Study Locations (19)

Florida

  • Urological Research Network - Hialeah
  • Lakeland Regional Health Systems - Lakeland
  • University of Miami Miller School of Medicine - Miami

Pennsylvania

  • Lancaster Urology - Lancaster
  • Thomas Jefferson University - Philadelphia
  • Fox Chase Cancer Center - Philadelphia

Colorado

  • University of Colorado, Denver Medical Campus - Aurora
  • The Urology Center of Colorado - Denver

Alaska

  • Alaska Urology Institute Alaska Clinical Research Center - Anchorage

California

  • Cedars-Sinai Medical Center - Los Angeles

Massachusetts

  • Brigham and Women's Hospital - Boston

Michigan

  • Spectrum Health Medical Group - Grand Rapids

New Jersey

  • Delaware Valley Urology, LLC - Voorhees Township

Trial Details

FieldValue
Enrollment Target 286 participants
Start Date 2014-05
Est. Completion 2017-02-01
Phase NA

Sponsor

GenomeDx Biosciences

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02080689

The ClinicalTrials.gov registry entry for NCT02080689 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 286 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (53% lower). The listed sponsor is GenomeDx Biosciences, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Decipher is the first listed.

NCT02080689 reports 19 study locations spanning 14 distinct geographic areas - top geographies include Florida, Pennsylvania, Colorado.

Frequently Asked Questions

What is clinical trial NCT02080689 about?

NCT02080689 is a clinical study titled "Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery". The influence of Decipher test on urologist and patient treatment plan choices immediately post RP and at the time of PSA rise or BCR

What is the current status of trial NCT02080689?

This trial is currently completed. It is a NA study. The enrollment target is 286 participants. The study started on 2014-05. Estimated completion is 2017-02-01.

What conditions does trial NCT02080689 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT02080689?

The interventions under investigation include: Decipher (OTHER).

Who is sponsoring clinical trial NCT02080689?

This trial is sponsored by GenomeDx Biosciences, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02080689 being conducted?

This trial has 19 study locations across Alaska, California, Colorado, Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Alaska

All trials with a study site in Alaska

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.